India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used in ...

Novartis Healthcare Pvt Ltd includes the Novartis Corporate Centre in Hyderabad, the commercial arm of Novartis in India, and R&D teams, which currently conduct clinical trials at more than 300 ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

in Hyderabad, has appointed former Novartis senior executive, Naveen Gullapalli, as managing director of Amgen India. Gullapalli will lead the Amgen India Technology and Innovation site in ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

Hyderabad: The queue of global pharma giants ... After pharma and biopharma biggies such as Amgen, Sanofi, Novartis, Bristol Myers Squibb, and Zoetis, the city is now learnt to be on the radar ...

WASHINGTON, Jan 16 - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis' blockbuster heart-failure drug Entresto after a U.S. appeals ...

IT and Industries Minister D Sridhar Babu, made significant strides in international economic diplomacy on Saturday by ...

Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...